Article | March 22, 2021

Bayer Evaluates Fibro For Scalable Single-Use mAb Purification

Source: Cytiva

By Ryan Zolyomi, Ian Scanlon#, Florence Rusly, Oliver Hardick#, Ashley Hesslein, and Hendri Tjandra. Biological Development – Isolation & Purification, Bayer U.S. LLC, Pharmaceuticals and Cytiva#

Cytiva-AKTA35

access the Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

Cytiva